• facebook
  • twitter
  • Share on whatsapp

Covaxin gets approval to run Phase 2/3 trials on 2- 18 year-olds! Fingers crossed.

The trials will take place in AIIMS Delhi, AIIMS Patna & Nagpur Meditrina Institute of Medical Science. It will take place on 525 subjects between this age group.

Like
Share

More posts like this



add